Found: 19
Select item for more details and to access through your institution.
Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness Model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of Trastuzumab on Health-Related Quality of Life in Patients With HER2-Positive Metastatic Breast Cancer: Data From Three Clinical Trials.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 288, doi. 10.3816/CBC.2010.n.037
- By:
- Publication type:
- Article
Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 3, p. 673, doi. 10.1007/s10549-014-2892-z
- By:
- Publication type:
- Article
Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 142, n. 3, p. 603, doi. 10.1007/s10549-013-2734-4
- By:
- Publication type:
- Article
Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan.
- Published in:
- Breast Cancer: Targets & Therapy, 2023, v. 15, p. 637, doi. 10.2147/BCTT.S420061
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Trastuzumab in the Adjuvant Setting for Treatment of HER2-Positive Breast Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 489, doi. 10.1002/cncr.22806
- By:
- Publication type:
- Article
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 2, p. 150, doi. 10.1002/ajh.20992
- By:
- Publication type:
- Article
Symptom Burden and Quality of Life among Women with HER2<sup>+</sup> Metastatic Breast Cancer.
- Published in:
- Breast Journal, 2015, v. 21, n. 2, p. 208, doi. 10.1111/tbj.12374
- By:
- Publication type:
- Article
Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer.
- Published in:
- Journal of Cancer Epidemiology, 2012, p. 1, doi. 10.1155/2012/819210
- By:
- Publication type:
- Article
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 17, p. 2657, doi. 10.1002/cncr.28710
- By:
- Publication type:
- Article
Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 5, p. 642, doi. 10.1002/cncr.28465
- By:
- Publication type:
- Article
Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 17, p. 3113, doi. 10.1002/cncr.28196
- By:
- Publication type:
- Article
Estimating Recurrences Prevented From Using Trastuzumab in HER-2/neu--Positive Adjuvant Breast Cancer in the United States.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 24, p. 5575, doi. 10.1002/cncr.25347
- By:
- Publication type:
- Article
What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?
- Published in:
- International Journal of Stroke, 2017, v. 12, n. 2, p. 137, doi. 10.1177/1747493016669887
- By:
- Publication type:
- Article
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
- Published in:
- International Journal of Stroke, 2016, v. 11, n. 2, p. 198, doi. 10.1177/1747493015609776
- By:
- Publication type:
- Article
Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting.
- Published in:
- Oncologist, 2014, v. 19, n. 9, p. 901, doi. 10.1634/theoncologist.2014-0059
- By:
- Publication type:
- Article
Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer: Results from the BCIRG 006 Study.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 812, doi. 10.1634/theoncologist.2013-0091
- By:
- Publication type:
- Article
Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries.
- Published in:
- 2019
- By:
- Publication type:
- Letter